Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Experimental Human Infection With Isogenic Mutants of Neisseria Gonorrhoeae
NCT03840811Phase 1Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Apr 2017
- Primary completion
- Nov 2019
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 1, open-label trial of Neisseria gonorrhoeae strain FA7537 in gonococcal infection, sponsored by National Institute of Allergy and Infectious Diseases. Started Apr 2017; status: completed.
02
Drugs
Neisseria gonorrhoeae strain FA7537
03
Conditions
gonococcal infection
Beyond the preview
Go deeper on NCT03840811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03840811.